Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center

Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center

Objective To compare the efficacy and prognosis of imatinib and sirolimus as second-line treatment for steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Clinical data of 33 patients diagnosed as SR-cGVHD afte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: HE Yundi, HUANG Ruihao, HONG Tao, WANG Weihao, DU Yuxuan
Formato: article
Lenguaje:ZH
Publicado: Editorial Office of Journal of Third Military Medical University 2021
Materias:
chronic graft-versus-host disease
allogeneic hematopoietic stem cell transplantation
imatinib
sirolimus
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/413c7351afd84e67a2f6d92b036de682
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares